TFFP insider transaction filings
TFF Pharmaceuticals, Inc. — 8 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-07-08. Screen TFFP transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for TFFP between 2026-06-11 and 2026-09-09. The table below lists the most recent filings on record.
Recent Form 4 filings — TFF Pharmaceuticals, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-07-08 | 4 | COLEMAN KIRK ALLEN — Chief Financial Officer | Grant/award (A): 10,184 @ $0 · Grant/award (A): 10,184 (derivative) @ $0 | EDGAR |
| 2024-07-08 | 4 | Mikhak Zamaneh — Chief Medical Officer | Grant/award (A): 10,184 @ $0 · Grant/award (A): 10,184 (derivative) @ $0 | EDGAR |
| 2024-07-08 | 4 | Weisman Harlan F — President and CEO, Director | Grant/award (A): 27,480 @ $0 · Grant/award (A): 27,480 (derivative) @ $0 | EDGAR |
| 2024-07-08 | 4 | Lee Catherine Chai-zon — Director | Grant/award (A): 1,583 @ $0 · Grant/award (A): 1,583 (derivative) @ $0 | EDGAR |
| 2024-07-08 | 4 | Roberts Brandi — Director | Grant/award (A): 3,165 @ $0 · Grant/award (A): 3,165 (derivative) @ $0 | EDGAR |
| 2024-07-08 | 4 | KING THOMAS BRAXTON — Director | Grant/award (A): 1,583 @ $0 · Grant/award (A): 1,583 (derivative) @ $0 | EDGAR |
| 2024-07-08 | 4 | MILLS ROBERT S — Director | Grant/award (A): 3,165 @ $0 · Grant/award (A): 3,165 (derivative) @ $0 | EDGAR |
| 2024-07-08 | 4 | ROCAMBOLI STEPHEN — Director | Grant/award (A): 3,165 @ $0 · Grant/award (A): 3,165 (derivative) @ $0 | EDGAR |
Recent 8-K events — TFF Pharmaceuticals, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-03-06 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-02-03 | 8-K | 3.02 — Unregistered Sales of Equity Securities 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
| 2024-12-10 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2024-11-14 | 8-K | 1.02 — Termination of a Material Definitive Agreement ? 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-08-06 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-07-01 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2024-06-07 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=TFFP returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →